Indonesia Expects Halal Certificate for Sinovac Experimental COVID-19 Vaccine

The highest Muslim clerical body in Indonesia is expected to issue a halal certification for the experimental COVID-19 vaccine developed by Chinese biopharmaceutical company Sinovac as doses already arrived, officials said on Dec. 7.

The highest Muslim clerical body in Indonesia is expected to issue a halal certification for the experimental COVID-19 vaccine developed by Chinese biopharmaceutical company Sinovac as doses already arrived, officials said on Dec. 7.

“A study by the Indonesian Ulema Council Halal Product Guarantee Agency and Institute for the Assessment of Food, Drugs and Cosmetics has been completed and has been submitted to the council for the making of a fatwa and halal certification,” Human Development and Culture Minister Muhadjir Effendy said.

Over one million doses of Sinovac’s experimental vaccine, called CoronaVac, arrived in Indonesia last Dec. 6 and another 1.8 million doses are expected to arrive next year.

Although the government has yet to release an exact schedule for the distribution of the vaccines that already arrived, first National Ambassador Nicholas Saputra of United Nations Children’s Fund Indonesia said that vaccination programs are expected to launch in the middle of 2021 once CoronaVac passes the third-phase clinical trials.

“The government will provide a vaccine that is proven safe and passes clinical trials under World Health Organization recommendations,” Health Minister Terawan Agus Putranto said.

State-owned vaccine manufacturer Bio Farma has been determining the efficacy of CoronaVac. After initially saying that clinical trials showed 97% efficacy, the company then said in a statement on Dec. 8 that the efficacy could not yet be determined. It added that the interim data from the third-phase clinical trials is expected to be available by January. 


© Fourth Estate® — All Rights Reserved.
This material may not be published, broadcast, rewritten or redistributed.